JP2022539604A5 - - Google Patents
Info
- Publication number
- JP2022539604A5 JP2022539604A5 JP2022500908A JP2022500908A JP2022539604A5 JP 2022539604 A5 JP2022539604 A5 JP 2022539604A5 JP 2022500908 A JP2022500908 A JP 2022500908A JP 2022500908 A JP2022500908 A JP 2022500908A JP 2022539604 A5 JP2022539604 A5 JP 2022539604A5
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- oxazin
- methanone
- pyrazino
- hexahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19185088.2 | 2019-07-09 | ||
| EP19185088 | 2019-07-09 | ||
| PCT/EP2020/069074 WO2021005034A1 (en) | 2019-07-09 | 2020-07-07 | New heterocyclic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539604A JP2022539604A (ja) | 2022-09-12 |
| JP2022539604A5 true JP2022539604A5 (https=) | 2025-02-07 |
| JP7649283B2 JP7649283B2 (ja) | 2025-03-19 |
Family
ID=67220669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500908A Active JP7649283B2 (ja) | 2019-07-09 | 2020-07-07 | 新規複素環化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220242876A1 (https=) |
| EP (1) | EP3997096B1 (https=) |
| JP (1) | JP7649283B2 (https=) |
| KR (1) | KR20220034104A (https=) |
| CN (1) | CN114096545A (https=) |
| AR (1) | AR119376A1 (https=) |
| AU (1) | AU2020311584A1 (https=) |
| BR (1) | BR112021026899A2 (https=) |
| CA (1) | CA3145338A1 (https=) |
| CL (1) | CL2022000019A1 (https=) |
| CO (1) | CO2022000186A2 (https=) |
| CR (1) | CR20220004A (https=) |
| IL (1) | IL288987A (https=) |
| MX (1) | MX2022000243A (https=) |
| PE (1) | PE20220515A1 (https=) |
| PH (1) | PH12021553249A1 (https=) |
| TW (1) | TW202116781A (https=) |
| WO (1) | WO2021005034A1 (https=) |
| ZA (1) | ZA202110352B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019134985A1 (en) | 2018-01-08 | 2019-07-11 | F. Hoffmann-La Roche Ag | Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors |
| PE20211089A1 (es) | 2018-08-13 | 2021-06-14 | Hoffmann La Roche | Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa |
| WO2020104494A1 (en) | 2018-11-22 | 2020-05-28 | F. Hoffmann-La Roche Ag | New heterocyclic compounds |
| CN114269755A (zh) | 2019-09-12 | 2022-04-01 | 豪夫迈·罗氏有限公司 | 作为magl抑制剂的4,4a,5,7,8,8a-六吡啶并[4,3-b][1,4]噁嗪-3-酮化合物 |
| CA3190277A1 (en) | 2020-09-03 | 2022-03-10 | Joerg Benz | Heterocyclic compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2014001946A (es) * | 2011-08-19 | 2014-03-27 | Merck Sharp & Dohme | Inhibidores del canal de potasio medularmente externo renal. |
| US9573961B2 (en) | 2012-12-19 | 2017-02-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| WO2017087863A1 (en) * | 2015-11-20 | 2017-05-26 | Abide Therapeutics, Inc. | Pyrazole compounds and methods of making and using same |
| EP3571202B1 (en) * | 2017-01-23 | 2021-06-30 | Pfizer Inc. | Heterocyclic spiro compounds as magl inhibitors |
| JOP20190267A1 (ar) * | 2017-05-23 | 2019-11-18 | Lundbeck La Jolla Research Center Inc | مثبطات بيرازول magl |
| JP7257387B2 (ja) * | 2017-08-29 | 2023-04-13 | ハー・ルンドベック・アクチエゼルスカベット | スピロ環化合物並びにその作製及び使用方法 |
| WO2019134985A1 (en) * | 2018-01-08 | 2019-07-11 | F. Hoffmann-La Roche Ag | Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors |
| MX2022000083A (es) * | 2019-07-03 | 2022-02-03 | Hoffmann La Roche | Inhibidores de monoacilglicerol lipasa (magl) heterociclicos. |
-
2020
- 2020-07-07 CN CN202080050165.3A patent/CN114096545A/zh active Pending
- 2020-07-07 AU AU2020311584A patent/AU2020311584A1/en not_active Abandoned
- 2020-07-07 CR CR20220004A patent/CR20220004A/es unknown
- 2020-07-07 PH PH1/2021/553249A patent/PH12021553249A1/en unknown
- 2020-07-07 JP JP2022500908A patent/JP7649283B2/ja active Active
- 2020-07-07 CA CA3145338A patent/CA3145338A1/en active Pending
- 2020-07-07 BR BR112021026899A patent/BR112021026899A2/pt not_active Application Discontinuation
- 2020-07-07 MX MX2022000243A patent/MX2022000243A/es unknown
- 2020-07-07 EP EP20740259.5A patent/EP3997096B1/en active Active
- 2020-07-07 WO PCT/EP2020/069074 patent/WO2021005034A1/en not_active Ceased
- 2020-07-07 KR KR1020227000611A patent/KR20220034104A/ko not_active Ceased
- 2020-07-07 PE PE2021002265A patent/PE20220515A1/es unknown
- 2020-07-08 TW TW109123050A patent/TW202116781A/zh unknown
- 2020-07-08 AR ARP200101928A patent/AR119376A1/es not_active Application Discontinuation
-
2021
- 2021-12-13 ZA ZA2021/10352A patent/ZA202110352B/en unknown
- 2021-12-14 IL IL288987A patent/IL288987A/en unknown
-
2022
- 2022-01-04 CL CL2022000019A patent/CL2022000019A1/es unknown
- 2022-01-06 US US17/569,749 patent/US20220242876A1/en active Pending
- 2022-01-13 CO CONC2022/0000186A patent/CO2022000186A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022539604A5 (https=) | ||
| JP7487421B2 (ja) | Ｐｒｍｔ５阻害剤 | |
| CN114040911B (zh) | 作为nav1.8抑制剂的2,3-二氢喹唑啉化合物 | |
| US11242334B2 (en) | Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof | |
| JP6068515B2 (ja) | セリン／トレオニンキナーゼ阻害剤 | |
| JP6200520B2 (ja) | 置換２−アミノピリジンプロテインキナーゼ阻害剤 | |
| WO2024238574A1 (en) | Cdk inhibitor compounds | |
| JP2021534139A (ja) | モノアシルグリセロールリパーゼ阻害剤としての新規の複素環化合物 | |
| KR20130062951A (ko) | 키누레닌 생성 억제 작용을 갖는 함질소 복소환 화합물 | |
| CN109843884B (zh) | 作为pde1抑制剂的咪唑并吡嗪酮、吡唑并嘧啶酮和吡唑并吡啶酮 | |
| JP7649283B2 (ja) | 新規複素環化合物 | |
| TW201738242A (zh) | 作為PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮 | |
| JP2024511389A (ja) | キナーゼ薬剤耐性変異に関連する疾患を治療するための複素環式化合物の使用及び方法 | |
| EP3302484A1 (en) | 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors | |
| JP2024160219A (ja) | てんかん治療用複素環化合物 | |
| JP2022544700A (ja) | 筋萎縮性側索硬化症および関連障害の治療のためにｔｄｐ－４３に結合する分子 | |
| CN115427109A (zh) | 作为二氢乳清酸脱氢酶抑制剂的杂环化合物 | |
| KR20240012538A (ko) | Map4k1 억제제로 사용하기 위한 피리미딘 화합물 | |
| JP2021187859A (ja) | 複素環化合物の医薬用途 | |
| WO2025179005A1 (en) | Molecular glues and uses thereof | |
| EP4590396A1 (en) | Pcsk9 inhibitors and methods of use thereof | |
| HK40068386A (en) | New heterocyclic compounds | |
| KR20230107542A (ko) | 헤테로방향족 화합물 및 이의 용도 | |
| HK40028694A (en) | Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof | |
| HK40028694B (en) | Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof |